Update to South Asian consensus guideline: Use of newer insulins in diabetes during Ramadan Revised Guidelines on the use of insulin in Ramadan

J Pak Med Assoc. 2016 Jun;66(6):777-8.

Abstract

This guidance is an update to the South Asian Consensus Guideline: Use of Insulin in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of insulin degludec (IDeg) and insulin degludec aspart (IDegAsp) during Ramadan. The suggestions contained herewith are based on the pharmacokinetic and pharmacodynamics properties of these novel insulins.

Keywords: Aspart, Degludec, Degludec aspart, Diabetes, Hypoglycaemia, Insulin, Ramadan..

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Fasting
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Insulin Aspart
  • Islam
  • Practice Guidelines as Topic

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Insulin Aspart